1. KD. Tripathi. Nonsteroidal Antiinflammatory Drugs and Antipyretic-Analgesics. Essentials of medical pharmacology. Seventh edition. 2013. Page – 204-205.
2. Tilo Grosser, Emer Smyth and Garret A. FitzGerald. Anti-inflammatory, Antipyretic and Analgesic agents; Pharmacotherapy of gout. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 12th Edition. New York McGraw Hill Medical 2011. Page – 985-986.
3. Gerald G. Briggs and Roger K. Freeman. E. A reference guide to fetal and neonatal risk: Drugs in Pregnancy and Lactation. Tenth Edition. 2015. Page – 1486-1488.
4. IPCA Laboratories Ltd. Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fasting Condition. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised on December 2012] [Accessed 8th January 2021] https://clinicaltrials.gov/ct2/show/NCT01735370
5. K Inoue, A Motonaga, T Nishimura, M Yokota, N Miki, H Fujisawa, F Ueda, Y Shibata, K Kimura. Mechanism of anti-inflammatory action of etodolac. NIH National Library of Medicine, National center for biotechnology information. Pubmed.gov. March 1991. [Accessed 8th January 2021] https://pubmed.ncbi.nlm.nih.gov/1714278/#:~:text=Etodolac%20inhibited%20bradykinin%2Dforming%20enzyme,unlike%20indomethacin%20or%20diclofenac%20Na.
6. Industrias Farmacéuticas Almirall, S.A. Electronic Medicines Compendium (EMC); [Revised on July 2019] [Accessed 8th January 2021] https://www.medicines.org.uk/emc/files/pil.3857.pdf
7. Cyndea Pharma and Laboratorium Sanitatis, S.L. Heads of Medical Agency (HMA). [Revised on October 2019] [Accessed 8th January 2021] https://mri.cts-mrp.eu/human/downloads/DK_H_2233_002_FinalPL.pdf
8. Wyeth Pharmaceuticals Inc. U.S. Food & Drug Administration. [Revised on July 2005] [Accessed 8th January 2021] https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/018922s022,020584s009lbl.pdf
9. Ranbaxy Ireland Ltd. Electronic Medicines Compendium (EMC); [Revised on July 2011] [Accessed 8th January 2021] https://www.medicines.org.uk/emc/files/pil.2216.pdf